» Articles » PMID: 28335478

Lactational Stage of Pasteurized Human Donor Milk Contributes to Nutrient Limitations for Infants

Overview
Journal Nutrients
Date 2017 Mar 25
PMID 28335478
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mother's own milk is the first choice for feeding preterm infants, but when not available, pasteurized human donor milk (PDM) is often used. Infants fed PDM have difficulties maintaining appropriate growth velocities. To assess the most basic elements of nutrition, we tested the hypotheses that fatty acid and amino acid composition of PDM is highly variable and standard pooling practices attenuate variability; however, total nutrients may be limiting without supplementation due to late lactational stage of the milk.

Methods: A prospective cross-sectional sampling of milk was obtained from five donor milk banks located in Ohio, Michigan, Colorado, Texas-Ft Worth, and California. Milk samples were collected after Institutional Review Board (#07-0035) approval and informed consent. Fatty acid and amino acid contents were measured in milk from individual donors and donor pools (pooled per Human Milk Banking Association of North America guidelines). Statistical comparisons were performed using Kruskal-Wallis, Spearman's, or Multivariate Regression analyses with center as the fixed factor and lactational stage as co-variate.

Results: Ten of the fourteen fatty acids and seventeen of the nineteen amino acids analyzed differed across Banks in the individual milk samples. Pooling minimized these differences in amino acid and fatty acid contents. Concentrations of lysine and docosahexaenoic acid (DHA) were not different across Banks, but concentrations were low compared to recommended levels.

Conclusions: Individual donor milk fatty acid and amino acid contents are highly variable. Standardized pooling practice reduces this variability. Lysine and DHA concentrations were consistently low across geographic regions in North America due to lactational stage of the milk, and thus not adequately addressed by pooling. Targeted supplementation is needed to optimize PDM, especially for the preterm or volume restricted infant.

Citing Articles

Randomized controlled trial of early arachidonic acid and docosahexaenoic acid enteral supplementation in very preterm infants.

Alvarez P, Ramiro-Cortijo D, Montes M, Moreno B, Calvo M, Liu G Front Pediatr. 2022; 10:947221.

PMID: 36090567 PMC: 9452757. DOI: 10.3389/fped.2022.947221.


DHA Supplementation Attenuates Inflammation-Associated Gene Expression in the Mammary Gland of Lactating Mothers Who Deliver Preterm.

Adams J, Valentine C, Karns R, Rogers L, Murase M, Fowler G J Nutr. 2022; 152(6):1404-1414.

PMID: 35199834 PMC: 9178958. DOI: 10.1093/jn/nxac043.


Human Milk Growth Factors and Their Role in NEC Prevention: A Narrative Review.

York D, Smazal A, Robinson D, De Plaen I Nutrients. 2021; 13(11).

PMID: 34836007 PMC: 8620589. DOI: 10.3390/nu13113751.


Determinants of fatty acid content and composition of human milk fed to infants born weighing <1250 g.

Hopperton K, Pitino M, Chouinard-Watkins R, Shama S, Sammut N, Bando N Am J Clin Nutr. 2021; 114(4):1523-1534.

PMID: 34254983 PMC: 8488876. DOI: 10.1093/ajcn/nqab222.


Human milk bank and personalized nutrition in the NICU: a narrative review.

Sanchez Luna M, Caballero Martin S, Gomez-de-Orgaz C Eur J Pediatr. 2020; 180(5):1327-1333.

PMID: 33244710 PMC: 7691070. DOI: 10.1007/s00431-020-03887-y.


References
1.
Ramel S, Demerath E, Gray H, Younge N, Boys C, Georgieff M . The relationship of poor linear growth velocity with neonatal illness and two-year neurodevelopment in preterm infants. Neonatology. 2012; 102(1):19-24. DOI: 10.1159/000336127. View

2.
Valentine C, Morrow G, Fernandez S, Gulati P, Bartholomew D, Long D . Docosahexaenoic Acid and Amino Acid Contents in Pasteurized Donor Milk are Low for Preterm Infants. J Pediatr. 2010; 157(6):906-10. DOI: 10.1016/j.jpeds.2010.06.017. View

3.
Cristofalo E, Schanler R, Blanco C, Sullivan S, Trawoeger R, Kiechl-Kohlendorfer U . Randomized trial of exclusive human milk versus preterm formula diets in extremely premature infants. J Pediatr. 2013; 163(6):1592-1595.e1. DOI: 10.1016/j.jpeds.2013.07.011. View

4.
Brent N . The risks and benefits of human donor breast milk. Pediatr Ann. 2013; 42(5):84-90. DOI: 10.3928/00904481-20130426-11. View

5.
Meier P, Patel A, Esquerra-Zwiers A . Donor Human Milk Update: Evidence, Mechanisms, and Priorities for Research and Practice. J Pediatr. 2016; 180:15-21. PMC: 5183469. DOI: 10.1016/j.jpeds.2016.09.027. View